FOGHORN THERAPEUTICS INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-1
Book Value Per Share
$-2
Free Cash Flow Per Share
$-1
Cash Per Share
$1
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity
96.5%
Return on Assets
-30.8%
Return on Invested Capital
88.6%
Debt to Equity
—
Current Ratio
2.73
Quick Ratio
2.73
Asset Turnover
0.13
R&D / Revenue
276.5%
SBC / Revenue
33.6%
Capex / Revenue
0.2%
Working Capital
$103M
Net Current Asset Value
$-143M
Invested Capital
$-109M
OCF / Net Income
1.16
FCF / Net Income
1.16
Accruals Ratio (Sloan)
6.0%
Net Debt
$-81M
Net Debt / EBITDA
0.97
Interest Coverage
—
Cash Coverage
—
Capex Coverage
-1721.98
Tangible Common Equity
$-109M
TCE / Total Assets
-54.8%
NOPAT
$-68M
Cash ROIC
111.9%
WC / Revenue
334.8%
Capex / D&A
0.02
Reinvestment Rate
3.8%
Asset Growth vs Revenue Growth
-67.0%
Revenue 5Y CAGR
135.1%
Stock Price (FY-end)
$5
Market Cap
$340M
P/S Ratio
11.00
P/B Ratio
—
P/TB Ratio
—
P/OCF Ratio
—
P/FCF Ratio
—
Enterprise Value
$259M
EV / Sales
8.39
EV / FCF
—
FCF Yield
-25.3%
Shareholder Yield
-3.1%
R&D Yield
25.1%
Capex Yield
0.0%
Shares Variation (YoY)
14.7%
Beta (5Y)
1.52
Cost of Equity
12.1%
Cost of Debt (after tax)
—
WACC
—
ROIC - WACC Spread
—
52W High
$7
52W Low
$3
Trailing Return 1Y
12.0%
Trailing Return 5Y
-78.2%
F-Score (Piotroski)
1.00
Z-Score (Altman)
-4.46
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.